Introduction
A letter arrives alleging patent infringement and demanding a royalty just below the cost of litigation. The pressure is deliberate: settle or spend more fighting than paying. This is the non-practicing entity (NPE) model – using litigation cost, not patent strength, as leverage. Many asserted patents are weak, overly broad, or poorly examined at the USPTO due to limited review time. The real risk isn’t always validity, but defense cost and uncertainty. Still, many NPE patents can be challenged with strong prior art and invalidity analysis. The key is shifting the strategy from reaction to structured defense, with invalidity at the center.
Part I: The First 30 Days After Receiving an NPE Demand
Do Not Panic. Do Not Pay. Do Not Ignore.
Three common mistakes follow an NPE demand letter:
- Panic and overpay: Settling immediately without analyzing validity or exposure often means paying for weak or invalid patents.
- Ignore the letter: Silence escalates risk into litigation without preparation, including loss of early invalidity leverage.
- Pay without negotiation: Initial demands are opening positions, not final prices—failure to negotiate leaves value on the table.
First 30 Days: Structured Response
Days 1–7: Immediate actions
- Preserve evidence and address litigation hold obligations.
- Identify asserted patents, claims, and full prosecution history via USPTO resources.
- Investigate the NPE: ownership, litigation history, and settlement patterns (e.g., via PACER records).
- Identify co-defendants for potential coordination.
- Begin preliminary validity review focused on whether the patent should have been granted.
Days 8–30: Build position
- Conduct prior art search (patents, publications, products, standards predating the priority date).
- Evaluate §112 issues: enablement, written description, and claim clarity.
- Obtain both invalidity and non-infringement opinions to assess exposure and defense strategy.
The first month determines leverage. Early invalidity work shapes whether the case trends toward quick settlement or credible defense.
Part II: Understanding the NPE’s Leverage – and How to Neutralize It
The Cost-of-Defense Business Model
NPE litigation works because defense is expensive. A federal patent case typically costs $3–5M through trial, while NPE demands are often $250K–$750K—intentionally below the cost of fighting. The leverage comes from risk avoidance, not patent strength.
How Invalidity Changes the Economics
An inter partes review (IPR) can shift the balance:
- Costs ~$50K–$150K to file
- Can fully invalidate asserted claims
- Even if unsuccessful, may narrow claims and strengthen district court defenses
- NPE patents are often more vulnerable due to lighter initial examination
A credible IPR increases NPE cost, delays resolution, and can disrupt the expectation of quick settlement.
The Willfulness Risk
After notice of infringement, continued activity can trigger willful infringement and up to 3× damages.
The key safeguard is an early opinion of counsel—assessing non-infringement or invalidity. It establishes good-faith reliance and helps mitigate willfulness exposure.
Part III: Invalidity Grounds – A Comprehensive Analysis
Prior Art: The Primary Attack
Anticipation under 35 U.S.C. § 102
A claim is anticipated – and therefore invalid – when a single prior art reference discloses every element of the claim. For NPE-asserted patents, anticipation is worth pursuing aggressively when you find a prior art reference that appears to cover the independent claims completely. Anticipation is the cleanest invalidity ground: if established, it cannot be overcome by the NPE’s secondary considerations arguments.
The effective anticipation search for an NPE patent looks first in the places the examiner did not look:
- Academic conference proceedings in the specific technical area
- Technical reports from government and military programs
- Products that were commercially available before the priority date – with documentation of their public availability
- Foreign patent applications, particularly from Japanese, Korean and European companies in the field
- Pre-filing Internet Archive captures of websites describing the relevant technology
Obviousness under 35 U.S.C. § 103
Most NPE invalidity challenges succeed on obviousness, not anticipation. The combination of two or three prior art references that collectively disclose all claim elements, with a documented motivation to combine, satisfies § 103 under the KSR standard.
Powerful obviousness combinations for NPE patents typically involve:
- A primary reference that discloses most of the claim elements
- A secondary reference that discloses the element the primary reference lacks
- A documented reason to combine – found in the prior art itself, in industry publications, in standards documents, or in the general knowledge of a POSITA
The KSR framework’s rejection of “teaching away” as an absolute bar to combination is particularly useful against NPE patents that claim novel combinations of existing technologies. Combining known elements using known methods to yield predictable results is the definition of obvious – and most NPE patents do exactly that.
§ 112 Invalidity Grounds
Written Description (§ 112(a))
The specification must demonstrate that the inventor was in possession of the claimed invention at the time of filing. Claims that are broader than anything described in the specification fail the written description requirement.
For NPE patents, written description attacks are most powerful when:
- The claims were broadened during prosecution beyond what was originally disclosed
- The specification describes a narrow preferred embodiment but the claims cover a broad genus
- Continuation applications filed years after the original include claims that are not supported by the original specification’s disclosure
Written description is not evaluated at the level of ordinary skill alone – it is evaluated by whether the specification actually says what the claims require. When it does not, the claim is invalid regardless of what a POSITA might have understood.
Enablement (§ 112(a))
The specification must enable a POSITA to make and use the full scope of the claimed invention without undue experimentation. For broad claims covering entire technical categories – “a method for wireless communication comprising…” – the enablement question is whether the specification provides enough information to enable the full breadth of the claim, not just the specific embodiments described.
Post-Amgen Inc. v. Sanofi (2023), the Supreme Court confirmed that broad functional claims require commensurately broad enablement. This decision has given defendants a powerful new tool against NPE patents that claim broad functional categories based on narrow technical disclosure.
Indefiniteness (§ 112(b))
Claims must point out and distinctly claim the subject matter with reasonable certainty. Under Nautilus, Inc. v. Biosig Instruments, Inc. (2014), a claim that fails to inform a POSITA of the scope of the invention with reasonable certainty is indefinite and therefore invalid.
NPE patent claims are disproportionately vulnerable to indefiniteness challenges because:
- They are often drafted broadly without clear technical boundaries
- Terms like “substantially,” “approximately,” “efficiently,” and “optimally” appear without specification anchors that define their meaning
- Functional limitations that could cover an unbounded range of implementations are common
Indefiniteness is a district court invalidity ground – it is not available in IPR. It is most effectively raised through a motion for claim construction that highlights the claim’s ambiguities and proposes a claim construction ruling that either definitively narrows the claim or finds it indefinite.
Derivation and Prior Invention
In rare but significant cases, the asserted invention was actually developed by someone other than the named inventor and that development is documented. Derivation proceedings before the PTAB are available when an applicant derived the claimed invention from another party. While less common than prior art attacks, this ground can be decisive when available.
Part IV: Selecting the Right Forum and Timing
Inter Partes Review: The Preferred Invalidity Vehicle
- IPR is the preferred forum for patent invalidity challenges in NPE defense for four reasons:
- Lower burden of proof. IPR uses the preponderance of the evidence standard. District court invalidity requires clear and convincing evidence. The same prior art combination that has a 50% chance in district court has a meaningfully higher probability of success in IPR.
- Faster resolution. IPR proceedings conclude within 12–18 months of institution. District court patent litigation typically runs 2–4 years. If the IPR cancels the asserted claims, the district court litigation ends. The time advantage is significant.
- Cost efficiency. A comprehensive IPR petition and proceeding costs $150,000–$300,000. Litigating through trial costs $3–5 million. Even a partially successful IPR – one that narrows claims rather than canceling them – can dramatically change the damages exposure and settlement dynamics.
- Stays of district court proceedings. Courts frequently grant stays of district court proceedings pending IPR. A stay eliminates the near-term litigation burden and expense while the PTAB evaluates the prior art. The NPE’s primary leverage – forcing you to spend on litigation now – is neutralized while the IPR proceeds.
Post-Grant Review (PGR): When Available
Post-Grant Review is available only for patents granted under the AIA (filed on or after March 16, 2013) and only within nine months of the patent’s grant date. PGR offers a significant advantage over IPR: it is not limited to § 102 and § 103 grounds – it also permits § 112 challenges (written description, enablement, indefiniteness), § 101 subject matter eligibility challenges and any other ground of invalidity.
For NPE assertions involving recently granted patents with § 112 or § 101 vulnerabilities, the PGR window is extremely valuable. Missing the nine-month window permanently forecloses the broader PGR grounds.
Monitor every asserted patent’s grant date and calculate the PGR window immediately.
District Court as the § 101 and § 112(b) Forum
Subject matter eligibility challenges under 35 U.S.C. § 101 – the Alice/Mayo framework – are not available in IPR. They must be raised in district court, typically through a motion to dismiss or motion for judgment on the pleadings at the outset of litigation.
For NPE patents in software, business methods and abstract process areas, § 101 is often the fastest and cheapest invalidity route. A successful § 101 motion can dispose of the entire case before claim construction, before significant discovery and before the defendant has spent most of its litigation budget.
The § 101 analysis asks two questions: (1) is the claim directed to a patent-ineligible concept (abstract idea, natural phenomenon, law of nature)? (2) if so, does the claim contain an inventive concept that transforms the ineligible concept into a patent-eligible application? NPE patents in software areas routinely fail this test.
Part V: Negotiation Strategy Informed by Invalidity
The Invalidity Threat as a Negotiation Tool
A credible invalidity case changes NPE settlement dynamics. When a defendant presents prior art, §101 issues, or §112 weaknesses early, it signals preparation and reduces extraction leverage.
Key pressure points:
- inter partes review (IPR) threat: Compelling prior art and a prepared IPR filing significantly raises risk for the NPE, since invalidation eliminates the patent entirely.
- Coalition defense: Coordinated invalidity work and joint IPRs across multiple defendants reduce cost and increase pressure on the NPE.
- Prosecution history leverage: Amendments made during prosecution can limit claim scope and weaken infringement positions.
When to Settle—and How
Settlement is a business decision based on litigation cost, invalidity strength, damages exposure, and portfolio risk.
If settling, invalidity analysis should anchor negotiations. Strong prior art or clear claim weaknesses directly reduce acceptable settlement value. NPE demands are typically anchored high; credible invalidity positions are what force them down.
Part VI: Special Situations in NPE Defense
The Portfolio Assertion
Some NPEs assert not one patent but a portfolio – ten, twenty, or fifty patents covering different aspects of a technology. Portfolio assertions are designed to overwhelm the defendant’s analysis capacity. You cannot perform a comprehensive invalidity analysis of fifty patents simultaneously.
The response to a portfolio assertion is triage:
- Identify which claims in which patents actually cover your products
- Rank the remaining patents by claim breadth and potential damages exposure
- Focus invalidity resources on the highest-exposure patents first
- Use IPR to dispose of the highest-value patents, creating a demonstration effect that deters assertion of the remainder
NPEs presenting portfolio assertions are often signaling that they want a portfolio license – a single payment covering all the patents – rather than individual patent litigation. The negotiation is about a business relationship, not individual patent merits. Invalidity of the core patents in the portfolio undermines the entire portfolio’s value as a negotiating asset.
The Standard-Essential Patent (SEP) Assertion
Some NPEs acquire patents that they claim are essential to industry standards – IEEE 802.11, 3GPP LTE/5G, Bluetooth – and assert them against implementers. SEP assertions involve specific legal frameworks beyond pure invalidity:
- FRAND commitment: If the patent was declared essential to a standard-setting organization under a FRAND (fair, reasonable and non-discriminatory) commitment, the NPE may be bound by that commitment. FRAND rate-setting is a distinct proceeding from invalidity.
- Standards body records: The history of the patent’s declaration to the standards body and the history of the standard’s development, is often the most important prior art record for SEP invalidity.
- Essentiality analysis: Many declared-essential patents are not actually technically essential – the standard can be implemented without them. A non-essentiality finding is effectively a non-infringement finding for all implementers.
SEP assertions require specialized counsel familiar with both patent invalidity and standards licensing law.
International Parallel Proceedings
NPEs increasingly file parallel actions in multiple jurisdictions – U.S. district court, Germany, the UK, China – with counterpart patents in each country. The international parallel action strategy is designed to fragment the defendant’s response, maximize legal costs and force jurisdiction-specific settlements.
For international parallel actions:
- Coordinate invalidity research across all jurisdictions using counterpart prior art that predates all parallel patents’ priority dates
- Identify jurisdiction-specific invalidity tools – Germany’s nullity proceedings, UK’s IPO invalidity proceedings, EPO Opposition – and evaluate each for strategic value
- Consider whether invalidity success in one jurisdiction creates pressure on the NPE’s overall assertion strategy across all jurisdictions
Part VII: Post-IPR Considerations
If the IPR Is Successful
A final written decision canceling the asserted claims ends the district court litigation as to those claims. The district court will typically dismiss the claims as moot. If the NPE has asserted multiple patents, the IPR proceeding addresses only the petitioned claims – other patents remain in play.
A canceled patent cannot be reasserted against any party. This is the permanent, portfolio-wide value of a successful IPR. If the NPE holds counterpart patents in the same family, consider whether the PTAB’s reasoning and the prior art record can be deployed against those family members in subsequent petitions.
If the IPR Is Partially Successful
The PTAB may cancel some claims while confirming others. Surviving claims return to district court with the benefit of having survived an IPR proceeding – the patent owner will argue that survived claims are stronger. The response is to maintain district court invalidity contentions on § 101 and § 112 grounds that were not available in IPR and to press non-infringement arguments against the narrowed surviving claims.
If the IPR Is Unsuccessful
An unsuccessful IPR is not a defeat. The estoppel provisions of § 315(e) prevent the petitioner from raising in district court any invalidity ground that was raised or reasonably could have been raised in IPR. This means the invalidity grounds that were not included in the IPR petition – § 101, § 112 and any prior art grounds deliberately excluded – are preserved for district court proceedings.
A strategic IPR petition anticipates this: include the best prior art grounds in the IPR; preserve § 101, § 112 and alternative prior art grounds for district court. This two-track approach ensures that invalidity arguments survive regardless of the IPR outcome.
Conclusion
NPE patent assertions are a persistent part of the IP landscape. The model is durable and the volume of assertable patents remains large. Outcomes for defendants depend less on legal spend and more on the strength of invalidity analysis and how strategically it is used. The NPE approach relies on defendants who don’t fully investigate prior art or challenge patent validity. Many asserted patents have weaknesses that can be exposed through prior art, §101, or §112 arguments, often via an inter partes review. When defendants actively challenge validity instead of settling by default, the leverage shifts – and many NPE assertions weaken under scrutiny.